• OPEN AN ACCOUNT
Indian Indices
Sensex
74,315.61 1,533.72
( 2.11%)
Global Indices
Nasdaq
52,191.76 549.28
(1.06%)
Dow Jones
7,764.37 24.43
(0.32%)
Hang Seng
64,657.00 -3,087.29
(-4.56%)
Nikkei 225
10,840.19 115.33
(1.08%)
Forex
USD-INR
95.22 -0.47
(-0.50%)
EUR-INR
106.51 -0.49
(-0.46%)
GBP-INR
126.04 -0.53
(-0.42%)
JPY-INR
0.60 0.00
(-0.36%)

EQUITY - MARKET SCREENER

Strides Pharma Science Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532531
INE939A01011
356.2353295
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
STAR
54.3
9779.06
EPS(TTM)
Face Value()
Div & Yield %
19.54
10
0.47
 

Shentracon Chemicals reports standalone net profit of Rs 0.09 crore in the March 2026 quarter
Jun 01,2026
Net profit of Shentracon Chemicals reported to Rs 0.09 crore in the quarter ended March 2026 as against net loss of Rs 0.27 crore during the previous quarter ended March 2025. Sales reported to Rs 0.05 crore in the quarter ended March 2026. There were no Sales reported during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 0.33 crore in the year ended March 2026 as against net loss of Rs 0.30 crore during the previous year ended March 2025. Sales reported to Rs 0.17 crore in the year ended March 2026. There were no Sales reported during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales0.050 0 0.170 0
OPM %40.000 -41.180 -
PBDT0.020.03 -33 0.070 0
PBT0.020.03 -33 0.070 0
NP0.09-0.27 LP -0.33-0.30 -10